Ferro V - Search Results

1

The Tortoise and the Hare: Evolving Regulatory Landscapes for Biosimilars.

Konara CS, Barnard RT, Hine D, Siegel E, Ferro V. Konara CS, et al. Among authors: ferro v. Trends Biotechnol. 2016 Jan;34(1):70-83. doi: 10.1016/j.tibtech.2015.10.009. Epub 2015 Nov 24. Trends Biotechnol. 2016. PMID: 26620970 Review.

2

Low-molecular-weight heparin biosimilars: potential implications for clinical practice. Australian Low-Molecular-Weight Heparin Biosimilar Working Group (ALBW).

Nandurkar H, Chong B, Salem H, Gallus A, Ferro V, McKinnon R; Australian Low-Molecular-Weight Heparin Biosimilar Working Group (ALBW). Nandurkar H, et al. Among authors: ferro v. Intern Med J. 2014 May;44(5):497-500. doi: 10.1111/imj.12417. Intern Med J. 2014. PMID: 24816308

3

Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.

Islam N, Ferro V. Islam N, et al. Among authors: ferro v. Nanoscale. 2016 Aug 14;8(30):14341-58. doi: 10.1039/c6nr03256g. Epub 2016 Jul 20. Nanoscale. 2016. PMID: 27439116 Review.

4

Investigations into the decomposition of aminoacyl-substituted monosaccharide scaffolds from a drug discovery library.

He QQ, Wimmer N, Verquin G, Meutermans W, Ferro V. He QQ, et al. Among authors: ferro v. Org Biomol Chem. 2015 Apr 7;13(13):4070-9. doi: 10.1039/c5ob00122f. Org Biomol Chem. 2015. PMID: 25736157

5

Glycosaminoglycans and Their Mimetics.

Ferro V. Ferro V. Molecules. 2016 Dec 25;22(1):20. doi: 10.3390/molecules22010020. Molecules. 2016. PMID: 28029141 Free PMC article.

6

Synthetic Approaches to L-Iduronic Acid and L-Idose: Key Building Blocks for the Preparation of Glycosaminoglycan Oligosaccharides.

Mohamed S, Ferro V. Mohamed S, et al. Among authors: ferro v. Adv Carbohydr Chem Biochem. 2015;72:21-61. doi: 10.1016/bs.accb.2015.07.001. Epub 2015 Oct 24. Adv Carbohydr Chem Biochem. 2015. PMID: 26613814 Review.

7

Applications of Ion Mobility-Mass Spectrometry in Carbohydrate Chemistry and Glycobiology.

Mu Y, Schulz BL, Ferro V. Mu Y, et al. Among authors: ferro v. Molecules. 2018 Oct 7;23(10):2557. doi: 10.3390/molecules23102557. Molecules. 2018. PMID: 30301275 Free PMC article. Review.

8

Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses.

Ferro V. Ferro V. Expert Opin Ther Targets. 2013 Aug;17(8):965-75. doi: 10.1517/14728222.2013.811491. Epub 2013 Jun 24. Expert Opin Ther Targets. 2013. PMID: 23789629 Review.

9

Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain.

Schuurs ZP, Hammond E, Elli S, Rudd TR, Mycroft-West CJ, Lima MA, Skidmore MA, Karlsson R, Chen YH, Bagdonaite I, Yang Z, Ahmed YA, Richard DJ, Turnbull J, Ferro V, Coombe DR, Gandhi NS. Schuurs ZP, et al. Among authors: ferro v. Comput Struct Biotechnol J. 2021;19:2806-2818. doi: 10.1016/j.csbj.2021.05.002. Epub 2021 May 4. Comput Struct Biotechnol J. 2021. PMID: 33968333 Free PMC article.

10

Synthesis and toxicological evaluation of a chitosan-L-leucine conjugate for pulmonary drug delivery applications.

Muhsin MD, George G, Beagley K, Ferro V, Armitage C, Islam N. Muhsin MD, et al. Among authors: ferro v. Biomacromolecules. 2014 Oct 13;15(10):3596-607. doi: 10.1021/bm5008635. Epub 2014 Sep 22. Biomacromolecules. 2014. PMID: 25191851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page